Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01736306 · ClinicalTrials.gov registry record
Biomarkers for Breast Cancer Risk in African American Women
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 260
- Enrollment target
NCT01736306: Completed study, sponsored by National Cancer Institute (NCI).
NCT01736306 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 260 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01736306 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 260 participants
- Enrollment target
Study Summary
Background: \- At present, women do not have very accurate tests to inform of them of their personal risk of developing breast cancer. More information on the changes associated with both benign and cancerous breast lesions will help develop better risk information. Researchers have been looking at cells found in breast milk to study genetic changes related to breast cancer. However, most of these cell samples have been collected from white women. A new study wants to collect breast milk samples from African American women for further research. Comparing the results of genetic tests will help improve understanding of breast cancer risk in all women. Objectives: \- To study genetic changes related to breast lesions, including breast cancer, in African American women. Eligibility: \- African American women at least 18 years of age who are nursing a baby and who either have had or are being considered for a breast biopsy. Design: * Participants will be screened with personal health questions. * Participants will receive a box with sterile bottles for milk collection. They will collect two breast milk samples, one from each breast. They will also fill out a questionnaire about their medical history. * The box with the samples and the questionnaire will be returned to the clinical center for study. * After the box is returned, participants will be asked to provide a copy of the biopsy report for any breast biopsies they have had. * There will be a followup phone call every year. Participants will provide health history information. This information will include whether they have been diagnosed with breast cancer in the previous year.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 260 participants |
| Start Date | 2012-07-23 |
| Est. Completion | 2020-03-27 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01736306
The ClinicalTrials.gov registry entry for NCT01736306 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 260 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01736306 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01736306 about?
NCT01736306 is a clinical study titled "Biomarkers for Breast Cancer Risk in African American Women". Background: \- At present, women do not have very accurate tests to inform of them of their personal risk of developing breast cancer. More information on the changes associated with both benign and cancerous breast lesions will help develop better risk information. Researchers have been looking at...
What is the current status of trial NCT01736306?
This trial is currently completed. The enrollment target is 260 participants. The study started on 2012-07-23. Estimated completion is 2020-03-27.
Who is sponsoring clinical trial NCT01736306?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.